Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Elementis, Encavis, Swiss Life Holding



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EUROPE RESEARCH ROUNDUP-Elementis, Encavis, Swiss Life Holding</title></head><body>

March 20 (Reuters) -Securities analysts revised their ratings and price targets on several European companies including Elementis, Encavis and Swiss Life Holding on Wednesday.


HIGHLIGHTS

* Assura AGRP.L: Peel Hunt cuts to add from buy

* Elementis Plc ELM.L: HSBC raises to buy from hold

* Encavis AG ECVG.DE: HSBC cuts to hold from buy

* Redcare Pharmacy NV RDC.DE: HSBC raises to hold from reduce

* Swiss Life Holding AG SLHN.S: HSBC raises target price to CHF 617 from CHF 615


Following is a summary of research actions on European companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.


* Adidas AG ADSGn.DE: RBC raises target price to EUR 230 from EUR 200

* Adyen NV ADYEN.AS: New Street Research raises to buy rating

* Assa Abloy AB ASSAb.ST: Bernstein raises target price to SEK 359 from SEK 340

* Assa Abloy AB ASSAb.ST: Citigroup raises target price to SEK 265 from SEK 255

* Assura AGRP.L: Peel Hunt cuts target price to 48p from 55p

* Assura AGRP.L: Peel Hunt cuts to add from buy

* Athens International Airport SA AIAr.AT: HSBC initiates coverage with hold rating

* Athens International Airport SA AIAr.AT: HSBC initiates target price EUR 8.4

* Banco Bpm BAMI.MI: Citigroup resumes coverage with buy rating; price target EUR 6.85

* BASF SE BASFn.DE: Berenberg raises to buy from hold; raises PT EUR 58 from EUR 50

* Beiersdorf AG BEIG.DE: Jefferies raises target price to EUR 155 from EUR 152

* Beneteau CHBE.PA: Portzamparc raises target price to EUR 17.8 from EUR 16; rating buy

* Buzzi BZU.MI: UBS raises target price to EUR 49 from EUR 46

* Bytes Technology Group Plc BYIT.L: Jefferies cuts target price to 560p from 670p

* Cdon AB CDONAB.ST: Jefferies initiates coverage with buy rating; price target SEK 195

* Close Brothers Group Plc CBRO.L: Berenberg raises target price to 470p from 425p

* Computacenter Plc CCC.L: Jefferies raises target price to 3,900p from 3,300p

* Cosmo Pharmaceuticals NV COPN.S: H.C. Wainwright initiates coverage with buy rating

* Cosmo Pharmaceuticals NV COPN.S: H.C. Wainwright initiates coverage with PT CHF 80

* Docmorris DOCM.S: HSBC raises target price to CHF 115 from CHF 80

* E.ON EONGn.DE: UBS raises target price to EUR 16 from EUR 14

* Elementis Plc ELM.L: HSBC raises target price to 170p from 150p

* Elementis Plc ELM.L: HSBC raises to buy from hold

* Encavis AG ECVG.DE: HSBC cuts target price to EUR 17.5 from EUR 18

* Encavis AG ECVG.DE: HSBC cuts to hold from buy

* Engie ENGIE.PA: HSBC raises target price to EUR 17 from EUR 16.5

* ENI ENI.MI: Berenberg cuts target price to EUR 15 from EUR 17.5

* ENI ENI.MI: Berenberg cuts to hold from buy

* Entain ENT.L: HSBC cuts target price to 940p from 1090p

* Fraport FRAG.DE: JP Morgan cuts target price to EUR 51 from EUR 57

* Givaudan SA GIVN.S: Barclays raises target price to CHF 3500 from CHF 3100

* Gran Tierra Energy Inc GTE.L: Peel Hunt cuts target price to 1850p from 2130p

* Groupe Crit SA CITT.PA: Midcap Partners raises PT to EUR 96 from EUR 94; rating buy

* Halma Plc HLMA.L: UBS raises target price to 2700p from 2220p

* Halma Plc HLMA.L: UBS raises to buy from neutral

* Italian Exhibition Group IEG.MI: Midcap Partners initiates coverage with rating buy

* Italian Exhibition Group IEG.MI: Midcap Partners raises PT to EUR 5.9 from EUR 5.5

* Jungheinrich AG JUNG_p.DE: Citigroup raises target price to EUR 35 from EUR 33

* Kardex Holding AG KARN.S: Berenberg cuts to hold from buy

* Kering PRTP.PA: Barclays cuts target price to EUR 390 from EUR 413

* Kering PRTP.PA: JP Morgan cuts target price to EUR 400 from EUR 425

* Lanxess LXSG.DE: HSBC raises target price to EUR 26 from EUR 25

* Lanxess LXSG.DE: Morgan Stanley cuts target price to EUR 22.5 from EUR 23.5

* Melrose Industries Plc MRON.L: UBS raises target price to 770p from 690p

* Merck KGaA MRCG.DE: Citigroup raises target price to EUR 210 from EUR 196

* Moncler MONC.MI: Citigroup raises target price to EUR 76.5 from EUR 64

* Nyxoah SA NYXH.BR: Degroof Petercam raises target price to EUR 21 from EUR 19

* Oersted A/S ORSTED.CO: RBC raises target price to DKK 380 from DKK 360

* Pearson PSON.L: JP Morgan raises target price to 1,220p from 1,200p

* Prodways Group PWG.PA: Midcap Partners cuts PT to EUR 1.0 from EUR 1.1; rating hold

* Rational AG RAAG.DE: Stifel initiates coverage with hold rating; PT EUR 800

* Redcare Pharmacy NV RDC.DE: HSBC raises target price to EUR 140 from EUR 90

* Redcare Pharmacy NV RDC.DE: HSBC raises to hold from reduce

* Sabre Insurance Group Plc SBRE.L: Berenberg raises target price to 211p from 200p

* Sabre Insurance Group Plc SBRE.L: RBC raises target price to 220p from 200p

* Saras SpA SRS.MI: Barclays cuts to equal-weight from overweight

* Saras SpA SRS.MI: Barclays raises target price to EUR 1.75 from EUR 1.70

* Schroders SDR.L: Morgan Stanley cuts target price to 441p from 514p

* Skanska SKAb.ST: UBS cuts to sell from neutral

* Skanska SKAb.ST: UBS raises target price to SEK 180 from SEK 152

* Spirax-Sarco SPX.L: UBS cuts target price to 11500p from 12500p

* Spirax-Sarco SPX.L: UBS cuts to neutral from buy

* Swiss Life Holding AG SLHN.S: HSBC raises target price to CHF 617 from CHF 615

* Syensqo SA SYENS.BR: Stifel cuts target price to EUR 119 from EUR 125

* Terna TRN.MI: Goldman Sachs raises to neutral

* Vat Group AG VACN.S: RBC raises target price to CHF 340 from CHF 280

* Verbund VERB.VI: UBS cuts target price to EUR 57.5 from EUR 60

* Virbac SA VIRB.PA: Midcap Partners raises PT to EUR 296 from EUR 292; rating hold

* Vossloh AG VOSG.DE: Baader Helvea initiates coverage with buy rating ; PT EUR 56

* Weir WEIR.L: UBS cuts target price to 2250p from 2500p

* Weir WEIR.L: UBS cuts to neutral from buy

* Wise Plc WISEa.L: Monness Crespi Hardt initiates with buy rating and 1,250p PT

* Yara YAR.OL: JP Morgan cuts target price to NOK 390 from NOK 430


(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.